Add like
Add dislike
Add to saved papers

Hypertension exaggerates renovascular resistance via miR-122-associated stress response in aging.

OBJECTIVE: Hypertension at advanced age damages microvasculature and initiates many disease conditions including chronic kidney disease (CKD). In the present study, we sought to determine molecular alterations occurring in angiotensin-II (Ang-II)-induced aged kidney.

METHODS: Old (75-80 weeks) and young (12-14 weeks) wild-type mice (C57BL/6J) were infused with Ang-II (1000 ng/kg per min) for 4 weeks using osmotic minipumps to induce hypertension. Blood pressure, renovascular density, and renal vascular resistance were measured by telemetry, barium angiography, and renal ultrasound, respectively. Molecular analysis was performed by RT-PCR, western blotting, and immunostaining.

RESULTS: Aged hypertensive mice showed significant increase in blood pressure, increased resistive index, and reduced vasculature compared with young mice with Ang-II. The cytoprotective and anti-inflammatory molecule hemeoxygenase-1 (Ho-1) was found to be downregulated in the hypertensive aged mice whereas its putative regulator Bach-1 was increased. Antagonistically, an increase in inflammatory chemokine Mcp-1 was observed in the same mice group along with an increase in extracellular matrix protein, collagen. In addition, DNA damage marker γH2AX was found to be high in hypertensive kidney, especially in aged hypertensive animals along with increased miR-122. Transfection with a mimic of miR-122 into mesangial cells showed an increase of Bach-1 expression and concomitant decease in Ho-1.

CONCLUSION: Our findings suggest that aged animals fail to counteract hypertensive condition resulting in upregulation of miR-122 and subsequently Bach-1, leading to decreased levels of Ho-1 and an increase in DNA damage and tissue inflammation. Together, these lead to increased collagen deposition thereby causing reduced vascular density and increased renal resistive index.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app